Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Ratios

LENZ Therapeutics (LENZ) Shares Issued (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Shares Issued for 4 consecutive years, with $648000.0 as the latest value for Q4 2025.

Quarterly Shares Issued rose 116.62% to $648000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $873000.0 for FY2025, N/A changed from the prior year.
Shares Issued for Q4 2025 was $648000.0 at LENZ Therapeutics, down from $26.1 million in the prior quarter.
The five-year high for Shares Issued was $26.1 million in Q2 2025, with the low at -$3.9 million in Q4 2024.
Average Shares Issued over 4 years is $3.0 million, with a median of $203000.0 recorded in 2023.
Peak annual rise in Shares Issued hit 664.72% in 2025, while the deepest fall reached 89.77% in 2025.
Over 4 years, Shares Issued stood at -$394000.0 in 2022, then soared by 151.52% to $203000.0 in 2023, then plummeted by 2021.18% to -$3.9 million in 2024, then soared by 116.62% to $648000.0 in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at $648000.0, $26.1 million, and $44000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.